nodes	percent_of_prediction	percent_of_DWPC	metapath
Exemestane—CYP19A1—Paclitaxel—lung cancer	0.211	0.357	CbGbCtD
Exemestane—CYP3A4—Topotecan—lung cancer	0.0539	0.0913	CbGbCtD
Exemestane—CYP3A4—Gefitinib—lung cancer	0.0493	0.0835	CbGbCtD
Exemestane—CYP3A4—Teniposide—lung cancer	0.0478	0.081	CbGbCtD
Exemestane—CYP3A4—Vinorelbine—lung cancer	0.038	0.0643	CbGbCtD
Exemestane—CYP3A4—Crizotinib—lung cancer	0.0302	0.0512	CbGbCtD
Exemestane—CYP3A4—Erlotinib—lung cancer	0.0292	0.0494	CbGbCtD
Exemestane—CYP3A4—Paclitaxel—lung cancer	0.0267	0.0452	CbGbCtD
Exemestane—CYP3A4—Irinotecan—lung cancer	0.0263	0.0446	CbGbCtD
Exemestane—CYP3A4—Vinblastine—lung cancer	0.0234	0.0397	CbGbCtD
Exemestane—CYP3A4—Etoposide—lung cancer	0.0211	0.0357	CbGbCtD
Exemestane—CYP3A4—Docetaxel—lung cancer	0.0193	0.0327	CbGbCtD
Exemestane—CYP3A4—Doxorubicin—lung cancer	0.0144	0.0244	CbGbCtD
Exemestane—Conjugated Estrogens—ABCC3—lung cancer	0.00101	0.167	CrCbGaD
Exemestane—Prednisolone—CYP2A6—lung cancer	0.000567	0.0933	CrCbGaD
Exemestane—CYP19A1—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	0.000495	0.00705	CbGpPWpGaD
Exemestane—Conjugated Estrogens—ABCG2—lung cancer	0.000493	0.0811	CrCbGaD
Exemestane—Estrone—ABCG2—lung cancer	0.000491	0.0809	CrCbGaD
Exemestane—CYP3A4—Tamoxifen metabolism—CYP2A6—lung cancer	0.000485	0.00691	CbGpPWpGaD
Exemestane—CYP19A1—Biological oxidations—GSTA3—lung cancer	0.000474	0.00676	CbGpPWpGaD
Exemestane—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—lung cancer	0.000473	0.00675	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—MSH6—lung cancer	0.000469	0.00668	CbGpPWpGaD
Exemestane—CYP19A1—Metapathway biotransformation—GSTA3—lung cancer	0.000468	0.00666	CbGpPWpGaD
Exemestane—CYP3A4—Estrogen metabolism—NQO1—lung cancer	0.000461	0.00657	CbGpPWpGaD
Exemestane—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC3—lung cancer	0.000452	0.00644	CbGpPWpGaD
Exemestane—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	0.000438	0.00625	CbGpPWpGaD
Exemestane—CYP19A1—Biological oxidations—GSTA4—lung cancer	0.000434	0.00618	CbGpPWpGaD
Exemestane—CYP19A1—Oxidation by Cytochrome P450—CYP1A1—lung cancer	0.000432	0.00616	CbGpPWpGaD
Exemestane—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—lung cancer	0.00043	0.00613	CbGpPWpGaD
Exemestane—CYP3A4—Xenobiotics—CYP2E1—lung cancer	0.000429	0.00611	CbGpPWpGaD
Exemestane—CYP19A1—Metapathway biotransformation—GSTA4—lung cancer	0.000428	0.0061	CbGpPWpGaD
Exemestane—CYP3A4—Constitutive Androstane Receptor Pathway—UGT1A1—lung cancer	0.000425	0.00605	CbGpPWpGaD
Exemestane—CYP19A1—Biological oxidations—GSTA2—lung cancer	0.000423	0.00602	CbGpPWpGaD
Exemestane—CYP3A4—Tamoxifen metabolism—CYP2E1—lung cancer	0.000412	0.00588	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—AHR—lung cancer	0.000409	0.00583	CbGpPWpGaD
Exemestane—CYP19A1—Biological oxidations—GSTA1—lung cancer	0.000408	0.00581	CbGpPWpGaD
Exemestane—CYP19A1—FSH signaling pathway—SRC—lung cancer	0.000399	0.00569	CbGpPWpGaD
Exemestane—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—lung cancer	0.000394	0.00561	CbGpPWpGaD
Exemestane—Estrone—CYP2E1—lung cancer	0.00039	0.0642	CrCbGaD
Exemestane—CYP19A1—Metapathway biotransformation—AKR1C1—lung cancer	0.000385	0.00549	CbGpPWpGaD
Exemestane—Estrone—CYP1A1—lung cancer	0.000385	0.0633	CrCbGaD
Exemestane—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—lung cancer	0.000381	0.00543	CbGpPWpGaD
Exemestane—CYP19A1—Biological oxidations—UGT1A1—lung cancer	0.000379	0.0054	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—NCOA3—lung cancer	0.000375	0.00534	CbGpPWpGaD
Exemestane—CYP19A1—Metapathway biotransformation—UGT1A1—lung cancer	0.000374	0.00533	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—COL4A3BP—lung cancer	0.000373	0.00531	CbGpPWpGaD
Exemestane—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—lung cancer	0.000368	0.00525	CbGpPWpGaD
Exemestane—CYP19A1—FSH signaling pathway—MAPK3—lung cancer	0.000368	0.00524	CbGpPWpGaD
Exemestane—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—lung cancer	0.00036	0.00514	CbGpPWpGaD
Exemestane—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—lung cancer	0.000356	0.00507	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—SMARCA4—lung cancer	0.000355	0.00507	CbGpPWpGaD
Exemestane—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	0.000355	0.00506	CbGpPWpGaD
Exemestane—CYP3A4—Estrogen metabolism—GSTM1—lung cancer	0.000353	0.00504	CbGpPWpGaD
Exemestane—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—lung cancer	0.000346	0.00493	CbGpPWpGaD
Exemestane—Estropipate—ALB—lung cancer	0.000344	0.0567	CrCbGaD
Exemestane—CYP3A4—Estrogen metabolism—CYP1A1—lung cancer	0.000335	0.00478	CbGpPWpGaD
Exemestane—CYP19A1—Tryptophan metabolism—MDM2—lung cancer	0.000334	0.00477	CbGpPWpGaD
Exemestane—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	0.000327	0.00466	CbGpPWpGaD
Exemestane—CYP19A1—Biological oxidations—HPGDS—lung cancer	0.000322	0.00459	CbGpPWpGaD
Exemestane—CYP3A4—Irinotecan Pathway—APC—lung cancer	0.000321	0.00457	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—ANXA1—lung cancer	0.000319	0.00454	CbGpPWpGaD
Exemestane—CYP19A1—Biological oxidations—GSTT1—lung cancer	0.000313	0.00445	CbGpPWpGaD
Exemestane—CYP19A1—Biological oxidations—CYP2A6—lung cancer	0.000309	0.0044	CbGpPWpGaD
Exemestane—CYP19A1—Biological oxidations—GCLC—lung cancer	0.000309	0.0044	CbGpPWpGaD
Exemestane—CYP3A4—Xenobiotics—CYP1A1—lung cancer	0.000308	0.00439	CbGpPWpGaD
Exemestane—Methylprednisolone—ABCB1—lung cancer	0.000299	0.0493	CrCbGaD
Exemestane—Testosterone—ABCG2—lung cancer	0.000299	0.0492	CrCbGaD
Exemestane—CYP3A4—Tamoxifen metabolism—CYP1A1—lung cancer	0.000296	0.00422	CbGpPWpGaD
Exemestane—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—lung cancer	0.000292	0.00416	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	0.000282	0.00403	CbGpPWpGaD
Exemestane—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—lung cancer	0.00028	0.004	CbGpPWpGaD
Exemestane—CYP19A1—Phase 1 - Functionalization of compounds—POMC—lung cancer	0.000265	0.00378	CbGpPWpGaD
Exemestane—CYP19A1—Biological oxidations—CYP2E1—lung cancer	0.000263	0.00374	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—STK11—lung cancer	0.00026	0.0037	CbGpPWpGaD
Exemestane—CYP19A1—Metapathway biotransformation—CYP2E1—lung cancer	0.000259	0.00369	CbGpPWpGaD
Exemestane—CYP19A1—FSH signaling pathway—AKT1—lung cancer	0.000248	0.00354	CbGpPWpGaD
Exemestane—Prednisone—ALB—lung cancer	0.00024	0.0395	CrCbGaD
Exemestane—Testosterone—CYP1A1—lung cancer	0.000234	0.0385	CrCbGaD
Exemestane—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—lung cancer	0.00023	0.00328	CbGpPWpGaD
Exemestane—Prednisone—ABCB1—lung cancer	0.000229	0.0377	CrCbGaD
Exemestane—CYP3A4—Tryptophan metabolism—CYP2E1—lung cancer	0.00022	0.00314	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	0.00022	0.00313	CbGpPWpGaD
Exemestane—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—lung cancer	0.000219	0.00312	CbGpPWpGaD
Exemestane—CYP19A1—Biological oxidations—GSTP1—lung cancer	0.000217	0.00309	CbGpPWpGaD
Exemestane—Estrone—ALB—lung cancer	0.000214	0.0353	CrCbGaD
Exemestane—CYP19A1—Metapathway biotransformation—GSTP1—lung cancer	0.000214	0.00305	CbGpPWpGaD
Exemestane—Prednisolone—ABCB1—lung cancer	0.000211	0.0347	CrCbGaD
Exemestane—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—lung cancer	0.000209	0.00298	CbGpPWpGaD
Exemestane—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—lung cancer	0.000207	0.00295	CbGpPWpGaD
Exemestane—Conjugated Estrogens—ABCB1—lung cancer	0.000205	0.0338	CrCbGaD
Exemestane—Estrone—ABCB1—lung cancer	0.000204	0.0337	CrCbGaD
Exemestane—Skin disorder—Etoposide—lung cancer	0.000203	0.00061	CcSEcCtD
Exemestane—Hyperhidrosis—Etoposide—lung cancer	0.000202	0.000607	CcSEcCtD
Exemestane—Feeling abnormal—Gemcitabine—lung cancer	0.000202	0.000606	CcSEcCtD
Exemestane—Dizziness—Vinorelbine—lung cancer	0.000202	0.000605	CcSEcCtD
Exemestane—Nervous system disorder—Paclitaxel—lung cancer	0.000201	0.000604	CcSEcCtD
Exemestane—Thrombocytopenia—Paclitaxel—lung cancer	0.000201	0.000603	CcSEcCtD
Exemestane—Anorexia—Etoposide—lung cancer	0.0002	0.000598	CcSEcCtD
Exemestane—Skin disorder—Paclitaxel—lung cancer	0.000199	0.000598	CcSEcCtD
Exemestane—CYP19A1—Biological oxidations—GSTM1—lung cancer	0.000199	0.00284	CbGpPWpGaD
Exemestane—Abdominal pain—Irinotecan—lung cancer	0.000199	0.000597	CcSEcCtD
Exemestane—Body temperature increased—Irinotecan—lung cancer	0.000199	0.000597	CcSEcCtD
Exemestane—Decreased appetite—Cisplatin—lung cancer	0.000199	0.000596	CcSEcCtD
Exemestane—Hyperhidrosis—Paclitaxel—lung cancer	0.000198	0.000595	CcSEcCtD
Exemestane—Gastrointestinal disorder—Cisplatin—lung cancer	0.000197	0.000592	CcSEcCtD
Exemestane—CYP19A1—Metapathway biotransformation—GSTM1—lung cancer	0.000196	0.0028	CbGpPWpGaD
Exemestane—Depression—Methotrexate—lung cancer	0.000196	0.000588	CcSEcCtD
Exemestane—Anorexia—Paclitaxel—lung cancer	0.000196	0.000587	CcSEcCtD
Exemestane—Pain—Cisplatin—lung cancer	0.000195	0.000586	CcSEcCtD
Exemestane—Vomiting—Vinorelbine—lung cancer	0.000194	0.000582	CcSEcCtD
Exemestane—Body temperature increased—Gemcitabine—lung cancer	0.000194	0.000581	CcSEcCtD
Exemestane—Rash—Vinorelbine—lung cancer	0.000192	0.000577	CcSEcCtD
Exemestane—Dermatitis—Vinorelbine—lung cancer	0.000192	0.000576	CcSEcCtD
Exemestane—Headache—Vinorelbine—lung cancer	0.000191	0.000573	CcSEcCtD
Exemestane—Leukopenia—Docetaxel—lung cancer	0.000191	0.000572	CcSEcCtD
Exemestane—CYP19A1—Biological oxidations—CYP1A1—lung cancer	0.000189	0.00269	CbGpPWpGaD
Exemestane—Sweating—Methotrexate—lung cancer	0.000188	0.000565	CcSEcCtD
Exemestane—Feeling abnormal—Cisplatin—lung cancer	0.000188	0.000565	CcSEcCtD
Exemestane—Paraesthesia—Etoposide—lung cancer	0.000188	0.000564	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—MMP1—lung cancer	0.000188	0.00268	CbGpPWpGaD
Exemestane—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000187	0.000561	CcSEcCtD
Exemestane—Dyspnoea—Etoposide—lung cancer	0.000187	0.00056	CcSEcCtD
Exemestane—CYP19A1—Metapathway biotransformation—CYP1A1—lung cancer	0.000186	0.00265	CbGpPWpGaD
Exemestane—Cough—Docetaxel—lung cancer	0.000186	0.000558	CcSEcCtD
Exemestane—Angina pectoris—Doxorubicin—lung cancer	0.000186	0.000558	CcSEcCtD
Exemestane—Hepatobiliary disease—Methotrexate—lung cancer	0.000186	0.000558	CcSEcCtD
Exemestane—Insomnia—Paclitaxel—lung cancer	0.000186	0.000557	CcSEcCtD
Exemestane—Hypersensitivity—Irinotecan—lung cancer	0.000185	0.000556	CcSEcCtD
Exemestane—Paraesthesia—Paclitaxel—lung cancer	0.000184	0.000553	CcSEcCtD
Exemestane—Hypertension—Docetaxel—lung cancer	0.000184	0.000552	CcSEcCtD
Exemestane—Bronchitis—Doxorubicin—lung cancer	0.000184	0.000551	CcSEcCtD
Exemestane—Dyspnoea—Paclitaxel—lung cancer	0.000183	0.000549	CcSEcCtD
Exemestane—Decreased appetite—Etoposide—lung cancer	0.000182	0.000546	CcSEcCtD
Exemestane—Myalgia—Docetaxel—lung cancer	0.000181	0.000544	CcSEcCtD
Exemestane—Chest pain—Docetaxel—lung cancer	0.000181	0.000544	CcSEcCtD
Exemestane—Arthralgia—Docetaxel—lung cancer	0.000181	0.000544	CcSEcCtD
Exemestane—Nausea—Vinorelbine—lung cancer	0.000181	0.000544	CcSEcCtD
Exemestane—Gastrointestinal disorder—Etoposide—lung cancer	0.000181	0.000542	CcSEcCtD
Exemestane—Dyspepsia—Paclitaxel—lung cancer	0.000181	0.000542	CcSEcCtD
Exemestane—Body temperature increased—Cisplatin—lung cancer	0.000181	0.000542	CcSEcCtD
Exemestane—Asthenia—Irinotecan—lung cancer	0.000181	0.000542	CcSEcCtD
Exemestane—Fatigue—Etoposide—lung cancer	0.00018	0.000541	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.00018	0.000541	CcSEcCtD
Exemestane—Pain—Etoposide—lung cancer	0.000179	0.000537	CcSEcCtD
Exemestane—Constipation—Etoposide—lung cancer	0.000179	0.000537	CcSEcCtD
Exemestane—Decreased appetite—Paclitaxel—lung cancer	0.000178	0.000535	CcSEcCtD
Exemestane—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	0.000178	0.00254	CbGpPWpGaD
Exemestane—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000177	0.000532	CcSEcCtD
Exemestane—Haemoglobin—Methotrexate—lung cancer	0.000177	0.000532	CcSEcCtD
Exemestane—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000177	0.000531	CcSEcCtD
Exemestane—Fatigue—Paclitaxel—lung cancer	0.000177	0.000531	CcSEcCtD
Exemestane—CYP3A4—Tryptophan metabolism—CAT—lung cancer	0.000177	0.00252	CbGpPWpGaD
Exemestane—Haemorrhage—Methotrexate—lung cancer	0.000177	0.000529	CcSEcCtD
Exemestane—Hepatitis—Methotrexate—lung cancer	0.000177	0.000529	CcSEcCtD
Exemestane—Asthenia—Gemcitabine—lung cancer	0.000176	0.000527	CcSEcCtD
Exemestane—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—lung cancer	0.000176	0.0025	CbGpPWpGaD
Exemestane—Constipation—Paclitaxel—lung cancer	0.000176	0.000526	CcSEcCtD
Exemestane—Pain—Paclitaxel—lung cancer	0.000176	0.000526	CcSEcCtD
Exemestane—Confusional state—Docetaxel—lung cancer	0.000175	0.000526	CcSEcCtD
Exemestane—Pharyngitis—Methotrexate—lung cancer	0.000175	0.000525	CcSEcCtD
Exemestane—Oedema—Docetaxel—lung cancer	0.000174	0.000522	CcSEcCtD
Exemestane—Weight increased—Doxorubicin—lung cancer	0.000174	0.000521	CcSEcCtD
Exemestane—Pruritus—Gemcitabine—lung cancer	0.000173	0.00052	CcSEcCtD
Exemestane—Infection—Docetaxel—lung cancer	0.000173	0.000518	CcSEcCtD
Exemestane—Feeling abnormal—Etoposide—lung cancer	0.000173	0.000517	CcSEcCtD
Exemestane—Diarrhoea—Irinotecan—lung cancer	0.000172	0.000516	CcSEcCtD
Exemestane—CYP3A4—Biological oxidations—GSTM2—lung cancer	0.000172	0.00245	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—CNDP2—lung cancer	0.000172	0.00245	CbGpPWpGaD
Exemestane—Gastrointestinal pain—Etoposide—lung cancer	0.000171	0.000513	CcSEcCtD
Exemestane—Nervous system disorder—Docetaxel—lung cancer	0.000171	0.000512	CcSEcCtD
Exemestane—Thrombocytopenia—Docetaxel—lung cancer	0.00017	0.000511	CcSEcCtD
Exemestane—Visual impairment—Methotrexate—lung cancer	0.00017	0.00051	CcSEcCtD
Exemestane—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	0.00017	0.00242	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—GSTM2—lung cancer	0.000169	0.00241	CbGpPWpGaD
Exemestane—Feeling abnormal—Paclitaxel—lung cancer	0.000169	0.000507	CcSEcCtD
Exemestane—Skin disorder—Docetaxel—lung cancer	0.000169	0.000507	CcSEcCtD
Exemestane—Hypersensitivity—Cisplatin—lung cancer	0.000168	0.000505	CcSEcCtD
Exemestane—Gastrointestinal pain—Paclitaxel—lung cancer	0.000168	0.000503	CcSEcCtD
Exemestane—Diarrhoea—Gemcitabine—lung cancer	0.000168	0.000503	CcSEcCtD
Exemestane—Erythema multiforme—Methotrexate—lung cancer	0.000167	0.0005	CcSEcCtD
Exemestane—Neuropathy peripheral—Doxorubicin—lung cancer	0.000167	0.0005	CcSEcCtD
Exemestane—Dizziness—Irinotecan—lung cancer	0.000166	0.000499	CcSEcCtD
Exemestane—Urticaria—Etoposide—lung cancer	0.000166	0.000499	CcSEcCtD
Exemestane—CYP19A1—Metabolism—COL4A3BP—lung cancer	0.000166	0.00237	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—AZIN2—lung cancer	0.000166	0.00237	CbGpPWpGaD
Exemestane—Anorexia—Docetaxel—lung cancer	0.000166	0.000497	CcSEcCtD
Exemestane—Body temperature increased—Etoposide—lung cancer	0.000165	0.000496	CcSEcCtD
Exemestane—Abdominal pain—Etoposide—lung cancer	0.000165	0.000496	CcSEcCtD
Exemestane—Urinary tract infection—Doxorubicin—lung cancer	0.000165	0.000496	CcSEcCtD
Exemestane—Asthenia—Cisplatin—lung cancer	0.000164	0.000492	CcSEcCtD
Exemestane—Cardiac disorder—Methotrexate—lung cancer	0.000164	0.000491	CcSEcCtD
Exemestane—Sweating—Doxorubicin—lung cancer	0.000163	0.000489	CcSEcCtD
Exemestane—Urticaria—Paclitaxel—lung cancer	0.000163	0.000489	CcSEcCtD
Exemestane—Abdominal pain—Paclitaxel—lung cancer	0.000162	0.000487	CcSEcCtD
Exemestane—Body temperature increased—Paclitaxel—lung cancer	0.000162	0.000487	CcSEcCtD
Exemestane—Hepatobiliary disease—Doxorubicin—lung cancer	0.000161	0.000483	CcSEcCtD
Exemestane—Vomiting—Irinotecan—lung cancer	0.00016	0.00048	CcSEcCtD
Exemestane—Sinusitis—Doxorubicin—lung cancer	0.00016	0.000479	CcSEcCtD
Exemestane—Immune system disorder—Methotrexate—lung cancer	0.000159	0.000478	CcSEcCtD
Exemestane—Rash—Irinotecan—lung cancer	0.000159	0.000476	CcSEcCtD
Exemestane—Dermatitis—Irinotecan—lung cancer	0.000159	0.000475	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000159	0.000475	CcSEcCtD
Exemestane—CYP3A4—Tryptophan metabolism—CYP1A1—lung cancer	0.000158	0.00225	CbGpPWpGaD
Exemestane—Headache—Irinotecan—lung cancer	0.000158	0.000473	CcSEcCtD
Exemestane—Insomnia—Docetaxel—lung cancer	0.000157	0.000472	CcSEcCtD
Exemestane—Diarrhoea—Cisplatin—lung cancer	0.000156	0.000469	CcSEcCtD
Exemestane—Paraesthesia—Docetaxel—lung cancer	0.000156	0.000468	CcSEcCtD
Exemestane—Alopecia—Methotrexate—lung cancer	0.000156	0.000468	CcSEcCtD
Exemestane—Vomiting—Gemcitabine—lung cancer	0.000156	0.000467	CcSEcCtD
Exemestane—CYP3A4—Biological oxidations—CYP2A7—lung cancer	0.000155	0.00221	CbGpPWpGaD
Exemestane—Dyspnoea—Docetaxel—lung cancer	0.000155	0.000465	CcSEcCtD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	0.000155	0.00221	CbGpPWpGaD
Exemestane—Mental disorder—Methotrexate—lung cancer	0.000155	0.000464	CcSEcCtD
Exemestane—Rash—Gemcitabine—lung cancer	0.000155	0.000464	CcSEcCtD
Exemestane—Dermatitis—Gemcitabine—lung cancer	0.000154	0.000463	CcSEcCtD
Exemestane—Hypersensitivity—Etoposide—lung cancer	0.000154	0.000463	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—BRAF—lung cancer	0.000154	0.0022	CbGpPWpGaD
Exemestane—Haemoglobin—Doxorubicin—lung cancer	0.000154	0.000461	CcSEcCtD
Exemestane—Headache—Gemcitabine—lung cancer	0.000154	0.000461	CcSEcCtD
Exemestane—Rhinitis—Doxorubicin—lung cancer	0.000153	0.000459	CcSEcCtD
Exemestane—Dyspepsia—Docetaxel—lung cancer	0.000153	0.000459	CcSEcCtD
Exemestane—CYP3A4—Metapathway biotransformation—CYP2A7—lung cancer	0.000153	0.00218	CbGpPWpGaD
Exemestane—Haemorrhage—Doxorubicin—lung cancer	0.000153	0.000458	CcSEcCtD
Exemestane—Hepatitis—Doxorubicin—lung cancer	0.000153	0.000458	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—CASP8—lung cancer	0.000153	0.00218	CbGpPWpGaD
Exemestane—Hypoaesthesia—Doxorubicin—lung cancer	0.000152	0.000456	CcSEcCtD
Exemestane—Pharyngitis—Doxorubicin—lung cancer	0.000152	0.000455	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—RB1—lung cancer	0.000152	0.00216	CbGpPWpGaD
Exemestane—Decreased appetite—Docetaxel—lung cancer	0.000151	0.000454	CcSEcCtD
Exemestane—Hypersensitivity—Paclitaxel—lung cancer	0.000151	0.000454	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—CDH1—lung cancer	0.000151	0.00215	CbGpPWpGaD
Exemestane—Oedema peripheral—Doxorubicin—lung cancer	0.000151	0.000451	CcSEcCtD
Exemestane—Gastrointestinal disorder—Docetaxel—lung cancer	0.00015	0.00045	CcSEcCtD
Exemestane—Asthenia—Etoposide—lung cancer	0.00015	0.00045	CcSEcCtD
Exemestane—Fatigue—Docetaxel—lung cancer	0.00015	0.00045	CcSEcCtD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	0.00015	0.00214	CbGpPWpGaD
Exemestane—Nausea—Irinotecan—lung cancer	0.00015	0.000448	CcSEcCtD
Exemestane—Constipation—Docetaxel—lung cancer	0.000149	0.000446	CcSEcCtD
Exemestane—Pain—Docetaxel—lung cancer	0.000149	0.000446	CcSEcCtD
Exemestane—Back pain—Methotrexate—lung cancer	0.000149	0.000446	CcSEcCtD
Exemestane—Pruritus—Etoposide—lung cancer	0.000148	0.000444	CcSEcCtD
Exemestane—Visual impairment—Doxorubicin—lung cancer	0.000147	0.000442	CcSEcCtD
Exemestane—Asthenia—Paclitaxel—lung cancer	0.000147	0.000442	CcSEcCtD
Exemestane—Nausea—Gemcitabine—lung cancer	0.000146	0.000437	CcSEcCtD
Exemestane—Vomiting—Cisplatin—lung cancer	0.000145	0.000436	CcSEcCtD
Exemestane—Pruritus—Paclitaxel—lung cancer	0.000145	0.000435	CcSEcCtD
Exemestane—Erythema multiforme—Doxorubicin—lung cancer	0.000145	0.000433	CcSEcCtD
Exemestane—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	0.000144	0.00206	CbGpPWpGaD
Exemestane—Rash—Cisplatin—lung cancer	0.000144	0.000432	CcSEcCtD
Exemestane—Dermatitis—Cisplatin—lung cancer	0.000144	0.000432	CcSEcCtD
Exemestane—Feeling abnormal—Docetaxel—lung cancer	0.000143	0.00043	CcSEcCtD
Exemestane—Diarrhoea—Etoposide—lung cancer	0.000143	0.00043	CcSEcCtD
Exemestane—Gastrointestinal pain—Docetaxel—lung cancer	0.000142	0.000427	CcSEcCtD
Exemestane—Cardiac disorder—Doxorubicin—lung cancer	0.000142	0.000425	CcSEcCtD
Exemestane—CYP19A1—Metabolism—ATP5H—lung cancer	0.000141	0.00201	CbGpPWpGaD
Exemestane—CYP19A1—Biological oxidations—POMC—lung cancer	0.000141	0.00201	CbGpPWpGaD
Exemestane—Diarrhoea—Paclitaxel—lung cancer	0.00014	0.000421	CcSEcCtD
Exemestane—Malaise—Methotrexate—lung cancer	0.000139	0.000416	CcSEcCtD
Exemestane—Dizziness—Etoposide—lung cancer	0.000138	0.000415	CcSEcCtD
Exemestane—CYP3A4—Biological oxidations—GSTA3—lung cancer	0.000138	0.00197	CbGpPWpGaD
Exemestane—Immune system disorder—Doxorubicin—lung cancer	0.000138	0.000414	CcSEcCtD
Exemestane—Body temperature increased—Docetaxel—lung cancer	0.000138	0.000412	CcSEcCtD
Exemestane—Abdominal pain—Docetaxel—lung cancer	0.000138	0.000412	CcSEcCtD
Exemestane—Leukopenia—Methotrexate—lung cancer	0.000138	0.000412	CcSEcCtD
Exemestane—CYP3A4—Metapathway biotransformation—GSTA3—lung cancer	0.000136	0.00194	CbGpPWpGaD
Exemestane—Dizziness—Paclitaxel—lung cancer	0.000136	0.000407	CcSEcCtD
Exemestane—Nausea—Cisplatin—lung cancer	0.000136	0.000407	CcSEcCtD
Exemestane—Alopecia—Doxorubicin—lung cancer	0.000135	0.000405	CcSEcCtD
Exemestane—Cough—Methotrexate—lung cancer	0.000134	0.000402	CcSEcCtD
Exemestane—Mental disorder—Doxorubicin—lung cancer	0.000134	0.000402	CcSEcCtD
Exemestane—Vomiting—Etoposide—lung cancer	0.000133	0.000399	CcSEcCtD
Exemestane—Rash—Etoposide—lung cancer	0.000132	0.000396	CcSEcCtD
Exemestane—Dermatitis—Etoposide—lung cancer	0.000132	0.000395	CcSEcCtD
Exemestane—Headache—Etoposide—lung cancer	0.000131	0.000393	CcSEcCtD
Exemestane—Myalgia—Methotrexate—lung cancer	0.000131	0.000392	CcSEcCtD
Exemestane—Arthralgia—Methotrexate—lung cancer	0.000131	0.000392	CcSEcCtD
Exemestane—Chest pain—Methotrexate—lung cancer	0.000131	0.000392	CcSEcCtD
Exemestane—Vomiting—Paclitaxel—lung cancer	0.000131	0.000391	CcSEcCtD
Exemestane—Testosterone—ALB—lung cancer	0.00013	0.0214	CrCbGaD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.00013	0.00039	CcSEcCtD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	0.00013	0.00185	CbGpPWpGaD
Exemestane—Rash—Paclitaxel—lung cancer	0.000129	0.000388	CcSEcCtD
Exemestane—Dermatitis—Paclitaxel—lung cancer	0.000129	0.000388	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—MDM2—lung cancer	0.000129	0.00184	CbGpPWpGaD
Exemestane—Back pain—Doxorubicin—lung cancer	0.000129	0.000386	CcSEcCtD
Exemestane—Headache—Paclitaxel—lung cancer	0.000129	0.000386	CcSEcCtD
Exemestane—Hypersensitivity—Docetaxel—lung cancer	0.000128	0.000384	CcSEcCtD
Exemestane—Muscle spasms—Doxorubicin—lung cancer	0.000128	0.000384	CcSEcCtD
Exemestane—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	0.000128	0.00182	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—GSTA4—lung cancer	0.000127	0.0018	CbGpPWpGaD
Exemestane—Confusional state—Methotrexate—lung cancer	0.000126	0.000379	CcSEcCtD
Exemestane—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—lung cancer	0.000126	0.0018	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PLBD1—lung cancer	0.000126	0.00179	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—MTOR—lung cancer	0.000126	0.00179	CbGpPWpGaD
Exemestane—Asthenia—Docetaxel—lung cancer	0.000125	0.000374	CcSEcCtD
Exemestane—CYP3A4—Metapathway biotransformation—GSTA4—lung cancer	0.000125	0.00178	CbGpPWpGaD
Exemestane—Infection—Methotrexate—lung cancer	0.000125	0.000374	CcSEcCtD
Exemestane—Nausea—Etoposide—lung cancer	0.000124	0.000373	CcSEcCtD
Exemestane—Testosterone—ABCB1—lung cancer	0.000124	0.0205	CrCbGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	0.000124	0.00176	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—GSTA2—lung cancer	0.000123	0.00176	CbGpPWpGaD
Exemestane—Pruritus—Docetaxel—lung cancer	0.000123	0.000369	CcSEcCtD
Exemestane—Nervous system disorder—Methotrexate—lung cancer	0.000123	0.000369	CcSEcCtD
Exemestane—Thrombocytopenia—Methotrexate—lung cancer	0.000123	0.000368	CcSEcCtD
Exemestane—Nausea—Paclitaxel—lung cancer	0.000122	0.000366	CcSEcCtD
Exemestane—Skin disorder—Methotrexate—lung cancer	0.000122	0.000365	CcSEcCtD
Exemestane—Hyperhidrosis—Methotrexate—lung cancer	0.000121	0.000364	CcSEcCtD
Exemestane—Malaise—Doxorubicin—lung cancer	0.00012	0.00036	CcSEcCtD
Exemestane—Anorexia—Methotrexate—lung cancer	0.00012	0.000358	CcSEcCtD
Exemestane—Leukopenia—Doxorubicin—lung cancer	0.000119	0.000357	CcSEcCtD
Exemestane—Diarrhoea—Docetaxel—lung cancer	0.000119	0.000357	CcSEcCtD
Exemestane—CYP3A4—Biological oxidations—GSTA1—lung cancer	0.000119	0.0017	CbGpPWpGaD
Exemestane—Cough—Doxorubicin—lung cancer	0.000116	0.000348	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—CASP3—lung cancer	0.000116	0.00165	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—HSD17B10—lung cancer	0.000115	0.00164	CbGpPWpGaD
Exemestane—Dizziness—Docetaxel—lung cancer	0.000115	0.000345	CcSEcCtD
Exemestane—Hypertension—Doxorubicin—lung cancer	0.000115	0.000344	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000114	0.000343	CcSEcCtD
Exemestane—Insomnia—Methotrexate—lung cancer	0.000113	0.00034	CcSEcCtD
Exemestane—Arthralgia—Doxorubicin—lung cancer	0.000113	0.00034	CcSEcCtD
Exemestane—Myalgia—Doxorubicin—lung cancer	0.000113	0.00034	CcSEcCtD
Exemestane—Chest pain—Doxorubicin—lung cancer	0.000113	0.00034	CcSEcCtD
Exemestane—Anxiety—Doxorubicin—lung cancer	0.000113	0.000338	CcSEcCtD
Exemestane—Paraesthesia—Methotrexate—lung cancer	0.000113	0.000338	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—CCND1—lung cancer	0.000113	0.0016	CbGpPWpGaD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000112	0.000337	CcSEcCtD
Exemestane—CYP3A4—Metapathway biotransformation—AKR1C1—lung cancer	0.000112	0.0016	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—JUN—lung cancer	0.000112	0.0016	CbGpPWpGaD
Exemestane—Dyspnoea—Methotrexate—lung cancer	0.000112	0.000335	CcSEcCtD
Exemestane—Vomiting—Docetaxel—lung cancer	0.000111	0.000332	CcSEcCtD
Exemestane—CYP3A4—Biological oxidations—UGT1A1—lung cancer	0.000111	0.00158	CbGpPWpGaD
Exemestane—Dyspepsia—Methotrexate—lung cancer	0.00011	0.000331	CcSEcCtD
Exemestane—Rash—Docetaxel—lung cancer	0.00011	0.000329	CcSEcCtD
Exemestane—Dermatitis—Docetaxel—lung cancer	0.00011	0.000329	CcSEcCtD
Exemestane—Confusional state—Doxorubicin—lung cancer	0.000109	0.000328	CcSEcCtD
Exemestane—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	0.000109	0.00155	CbGpPWpGaD
Exemestane—Decreased appetite—Methotrexate—lung cancer	0.000109	0.000327	CcSEcCtD
Exemestane—Headache—Docetaxel—lung cancer	0.000109	0.000327	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—PTEN—lung cancer	0.000109	0.00155	CbGpPWpGaD
Exemestane—Oedema—Doxorubicin—lung cancer	0.000109	0.000326	CcSEcCtD
Exemestane—Gastrointestinal disorder—Methotrexate—lung cancer	0.000108	0.000325	CcSEcCtD
Exemestane—Fatigue—Methotrexate—lung cancer	0.000108	0.000324	CcSEcCtD
Exemestane—Infection—Doxorubicin—lung cancer	0.000108	0.000323	CcSEcCtD
Exemestane—Pain—Methotrexate—lung cancer	0.000107	0.000322	CcSEcCtD
Exemestane—CYP19A1—Metabolism—CKB—lung cancer	0.000107	0.00152	CbGpPWpGaD
Exemestane—Nervous system disorder—Doxorubicin—lung cancer	0.000106	0.000319	CcSEcCtD
Exemestane—Thrombocytopenia—Doxorubicin—lung cancer	0.000106	0.000319	CcSEcCtD
Exemestane—Skin disorder—Doxorubicin—lung cancer	0.000105	0.000316	CcSEcCtD
Exemestane—Hyperhidrosis—Doxorubicin—lung cancer	0.000105	0.000315	CcSEcCtD
Exemestane—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	0.000104	0.00148	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—EP300—lung cancer	0.000104	0.00148	CbGpPWpGaD
Exemestane—Anorexia—Doxorubicin—lung cancer	0.000104	0.00031	CcSEcCtD
Exemestane—Nausea—Docetaxel—lung cancer	0.000103	0.00031	CcSEcCtD
Exemestane—Feeling abnormal—Methotrexate—lung cancer	0.000103	0.00031	CcSEcCtD
Exemestane—Gastrointestinal pain—Methotrexate—lung cancer	0.000103	0.000307	CcSEcCtD
Exemestane—CYP19A1—Metabolism—GSTM2—lung cancer	0.000101	0.00143	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CNDP2—lung cancer	0.000101	0.00143	CbGpPWpGaD
Exemestane—Urticaria—Methotrexate—lung cancer	9.96e-05	0.000299	CcSEcCtD
Exemestane—Body temperature increased—Methotrexate—lung cancer	9.91e-05	0.000297	CcSEcCtD
Exemestane—Abdominal pain—Methotrexate—lung cancer	9.91e-05	0.000297	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Doxorubicin—lung cancer	9.89e-05	0.000297	CcSEcCtD
Exemestane—Insomnia—Doxorubicin—lung cancer	9.82e-05	0.000295	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—lung cancer	9.81e-05	0.0014	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—MTMR3—lung cancer	9.78e-05	0.00139	CbGpPWpGaD
Exemestane—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	9.76e-05	0.00139	CbGpPWpGaD
Exemestane—Paraesthesia—Doxorubicin—lung cancer	9.75e-05	0.000292	CcSEcCtD
Exemestane—Dyspnoea—Doxorubicin—lung cancer	9.68e-05	0.00029	CcSEcCtD
Exemestane—Dyspepsia—Doxorubicin—lung cancer	9.56e-05	0.000287	CcSEcCtD
Exemestane—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	9.54e-05	0.00136	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PGAM1—lung cancer	9.53e-05	0.00136	CbGpPWpGaD
Exemestane—Decreased appetite—Doxorubicin—lung cancer	9.44e-05	0.000283	CcSEcCtD
Exemestane—CYP3A4—Biological oxidations—HPGDS—lung cancer	9.4e-05	0.00134	CbGpPWpGaD
Exemestane—Gastrointestinal disorder—Doxorubicin—lung cancer	9.37e-05	0.000281	CcSEcCtD
Exemestane—Fatigue—Doxorubicin—lung cancer	9.36e-05	0.000281	CcSEcCtD
Exemestane—Pain—Doxorubicin—lung cancer	9.29e-05	0.000278	CcSEcCtD
Exemestane—Constipation—Doxorubicin—lung cancer	9.29e-05	0.000278	CcSEcCtD
Exemestane—Hypersensitivity—Methotrexate—lung cancer	9.24e-05	0.000277	CcSEcCtD
Exemestane—CYP3A4—Biological oxidations—GSTT1—lung cancer	9.12e-05	0.0013	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CYP2A7—lung cancer	9.1e-05	0.0013	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—MYC—lung cancer	9.03e-05	0.00129	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—CYP2A6—lung cancer	9.02e-05	0.00129	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—GCLC—lung cancer	9.02e-05	0.00129	CbGpPWpGaD
Exemestane—Asthenia—Methotrexate—lung cancer	9e-05	0.00027	CcSEcCtD
Exemestane—Feeling abnormal—Doxorubicin—lung cancer	8.95e-05	0.000268	CcSEcCtD
Exemestane—CYP19A1—Metabolism—SDC4—lung cancer	8.9e-05	0.00127	CbGpPWpGaD
Exemestane—Gastrointestinal pain—Doxorubicin—lung cancer	8.88e-05	0.000266	CcSEcCtD
Exemestane—Pruritus—Methotrexate—lung cancer	8.87e-05	0.000266	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—EGFR—lung cancer	8.83e-05	0.00126	CbGpPWpGaD
Exemestane—Urticaria—Doxorubicin—lung cancer	8.63e-05	0.000259	CcSEcCtD
Exemestane—Body temperature increased—Doxorubicin—lung cancer	8.58e-05	0.000257	CcSEcCtD
Exemestane—Abdominal pain—Doxorubicin—lung cancer	8.58e-05	0.000257	CcSEcCtD
Exemestane—Diarrhoea—Methotrexate—lung cancer	8.58e-05	0.000257	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—KRAS—lung cancer	8.34e-05	0.00119	CbGpPWpGaD
Exemestane—Dizziness—Methotrexate—lung cancer	8.29e-05	0.000249	CcSEcCtD
Exemestane—CYP19A1—Metabolism—RRM1—lung cancer	8.11e-05	0.00116	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GSTA3—lung cancer	8.11e-05	0.00116	CbGpPWpGaD
Exemestane—Hypersensitivity—Doxorubicin—lung cancer	8e-05	0.00024	CcSEcCtD
Exemestane—Vomiting—Methotrexate—lung cancer	7.97e-05	0.000239	CcSEcCtD
Exemestane—Rash—Methotrexate—lung cancer	7.91e-05	0.000237	CcSEcCtD
Exemestane—Dermatitis—Methotrexate—lung cancer	7.9e-05	0.000237	CcSEcCtD
Exemestane—Headache—Methotrexate—lung cancer	7.86e-05	0.000236	CcSEcCtD
Exemestane—Asthenia—Doxorubicin—lung cancer	7.79e-05	0.000234	CcSEcCtD
Exemestane—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	7.73e-05	0.0011	CbGpPWpGaD
Exemestane—Pruritus—Doxorubicin—lung cancer	7.68e-05	0.00023	CcSEcCtD
Exemestane—CYP3A4—Biological oxidations—CYP2E1—lung cancer	7.67e-05	0.00109	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—B4GALT5—lung cancer	7.62e-05	0.00109	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	7.56e-05	0.00108	CbGpPWpGaD
Exemestane—Nausea—Methotrexate—lung cancer	7.45e-05	0.000223	CcSEcCtD
Exemestane—Diarrhoea—Doxorubicin—lung cancer	7.43e-05	0.000223	CcSEcCtD
Exemestane—CYP19A1—Metabolism—GSTA4—lung cancer	7.41e-05	0.00106	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—TP53—lung cancer	7.41e-05	0.00106	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	7.25e-05	0.00103	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GSTA2—lung cancer	7.23e-05	0.00103	CbGpPWpGaD
Exemestane—Dizziness—Doxorubicin—lung cancer	7.18e-05	0.000215	CcSEcCtD
Exemestane—CYP19A1—Metabolism—GSTA1—lung cancer	6.97e-05	0.000994	CbGpPWpGaD
Exemestane—Vomiting—Doxorubicin—lung cancer	6.9e-05	0.000207	CcSEcCtD
Exemestane—CYP19A1—Metabolism—ABCC3—lung cancer	6.89e-05	0.000983	CbGpPWpGaD
Exemestane—Rash—Doxorubicin—lung cancer	6.85e-05	0.000205	CcSEcCtD
Exemestane—Dermatitis—Doxorubicin—lung cancer	6.84e-05	0.000205	CcSEcCtD
Exemestane—Headache—Doxorubicin—lung cancer	6.8e-05	0.000204	CcSEcCtD
Exemestane—CYP19A1—Metabolism—AKR1C1—lung cancer	6.68e-05	0.000952	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—UGT1A1—lung cancer	6.48e-05	0.000924	CbGpPWpGaD
Exemestane—Nausea—Doxorubicin—lung cancer	6.45e-05	0.000193	CcSEcCtD
Exemestane—CYP3A4—Biological oxidations—GSTP1—lung cancer	6.32e-05	0.000901	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—AKT1—lung cancer	6.26e-05	0.000892	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GNG11—lung cancer	6.25e-05	0.000891	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	6.24e-05	0.000889	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—APOA1—lung cancer	6.22e-05	0.000886	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ALDOA—lung cancer	5.95e-05	0.000848	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—GSTM1—lung cancer	5.81e-05	0.000828	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—NCOA3—lung cancer	5.78e-05	0.000823	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	5.73e-05	0.000817	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	5.68e-05	0.000809	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ADCY1—lung cancer	5.62e-05	0.000801	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ABCG2—lung cancer	5.62e-05	0.000801	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—HPGDS—lung cancer	5.51e-05	0.000785	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ENO2—lung cancer	5.51e-05	0.000785	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—CYP1A1—lung cancer	5.51e-05	0.000785	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PPP2R1B—lung cancer	5.48e-05	0.000781	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	5.43e-05	0.000774	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—POMC—lung cancer	5.4e-05	0.00077	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GSTT1—lung cancer	5.34e-05	0.000762	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CYP2A6—lung cancer	5.28e-05	0.000753	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GCLC—lung cancer	5.28e-05	0.000753	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	5.26e-05	0.00075	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ENO1—lung cancer	5.01e-05	0.000714	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	4.99e-05	0.000711	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—ALB—lung cancer	4.93e-05	0.000702	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—COL4A3BP—lung cancer	4.84e-05	0.000691	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—AZIN2—lung cancer	4.84e-05	0.000691	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CYP2E1—lung cancer	4.49e-05	0.00064	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—NQO1—lung cancer	4.44e-05	0.000633	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.35e-05	0.00062	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.31e-05	0.000614	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ATP5H—lung cancer	4.12e-05	0.000587	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—POMC—lung cancer	4.11e-05	0.000585	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—STK11—lung cancer	4e-05	0.000571	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.76e-05	0.000536	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GSTP1—lung cancer	3.7e-05	0.000528	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PLBD1—lung cancer	3.67e-05	0.000523	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CAT—lung cancer	3.61e-05	0.000514	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.58e-05	0.000511	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ABCB1—lung cancer	3.51e-05	0.0005	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—TYMS—lung cancer	3.44e-05	0.000491	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GSTM1—lung cancer	3.4e-05	0.000485	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—HSD17B10—lung cancer	3.36e-05	0.000479	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CYP1A1—lung cancer	3.23e-05	0.00046	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ERCC2—lung cancer	3.2e-05	0.000456	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CKB—lung cancer	3.12e-05	0.000445	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTM2—lung cancer	2.94e-05	0.000418	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CNDP2—lung cancer	2.94e-05	0.000418	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—MTMR3—lung cancer	2.86e-05	0.000407	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PGAM1—lung cancer	2.78e-05	0.000397	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—APOA1—lung cancer	2.77e-05	0.000395	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP2A7—lung cancer	2.65e-05	0.000378	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.65e-05	0.000378	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SDC4—lung cancer	2.6e-05	0.00037	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PIK3CG—lung cancer	2.53e-05	0.00036	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—POMC—lung cancer	2.41e-05	0.000343	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTA3—lung cancer	2.37e-05	0.000337	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—RRM1—lung cancer	2.37e-05	0.000337	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CREBBP—lung cancer	2.34e-05	0.000334	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—B4GALT5—lung cancer	2.22e-05	0.000317	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PIK3CD—lung cancer	2.22e-05	0.000317	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ALB—lung cancer	2.19e-05	0.000313	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTA4—lung cancer	2.16e-05	0.000308	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTA2—lung cancer	2.11e-05	0.000301	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTA1—lung cancer	2.03e-05	0.00029	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ABCC3—lung cancer	2.01e-05	0.000287	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—AKR1C1—lung cancer	1.95e-05	0.000278	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PIK3CB—lung cancer	1.94e-05	0.000276	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PTGS2—lung cancer	1.92e-05	0.000274	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—UGT1A1—lung cancer	1.89e-05	0.00027	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GNG11—lung cancer	1.82e-05	0.00026	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ALDOA—lung cancer	1.74e-05	0.000248	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NCOA3—lung cancer	1.69e-05	0.00024	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PTEN—lung cancer	1.67e-05	0.000239	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ADCY1—lung cancer	1.64e-05	0.000234	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ABCG2—lung cancer	1.64e-05	0.000234	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—HPGDS—lung cancer	1.61e-05	0.000229	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ENO2—lung cancer	1.61e-05	0.000229	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.6e-05	0.000228	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—EP300—lung cancer	1.6e-05	0.000228	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTT1—lung cancer	1.56e-05	0.000222	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP2A6—lung cancer	1.54e-05	0.00022	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GCLC—lung cancer	1.54e-05	0.00022	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ENO1—lung cancer	1.46e-05	0.000208	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP2E1—lung cancer	1.31e-05	0.000187	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NQO1—lung cancer	1.3e-05	0.000185	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PIK3CA—lung cancer	1.18e-05	0.000168	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—STK11—lung cancer	1.17e-05	0.000167	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTP1—lung cancer	1.08e-05	0.000154	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CAT—lung cancer	1.05e-05	0.00015	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ABCB1—lung cancer	1.02e-05	0.000146	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—TYMS—lung cancer	1.01e-05	0.000143	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTM1—lung cancer	9.94e-06	0.000142	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—AKT1—lung cancer	9.65e-06	0.000137	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP1A1—lung cancer	9.42e-06	0.000134	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ERCC2—lung cancer	9.34e-06	0.000133	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—APOA1—lung cancer	8.08e-06	0.000115	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PIK3CG—lung cancer	7.38e-06	0.000105	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—POMC—lung cancer	7.02e-06	0.0001	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CREBBP—lung cancer	6.84e-06	9.75e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PIK3CD—lung cancer	6.49e-06	9.24e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ALB—lung cancer	6.4e-06	9.13e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PIK3CB—lung cancer	5.65e-06	8.06e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PTGS2—lung cancer	5.6e-06	7.98e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PTEN—lung cancer	4.88e-06	6.96e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—EP300—lung cancer	4.66e-06	6.64e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PIK3CA—lung cancer	3.45e-06	4.91e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—AKT1—lung cancer	2.82e-06	4.01e-05	CbGpPWpGaD
